الرئيسية › سرطان البروستاتا › بنسلفانيا › Philadelphia
التجارب السريرية لـ سرطان البروستاتا في Philadelphia، PA
44 دراسات لـ سرطان البروستاتا تبحث عن مشاركين في مواقع داخل وحول Philadelphia (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
جارٍ التسجيلالمرحلة 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · على بُعد 13 ميل
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · على بُعد 22 ميل
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Sidney Kimmel Cancer Center - Jefferson Health, Philadelphia
DESTINY-PANTUMOUR04
جارٍ التسجيلدراسة رصدية
- Research Site, Philadelphia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
جارٍ التسجيلالمرحلة 3
- Fox Chase Cancer Center ( Site 0076), Philadelphia
- MidLantic urology ( Site 0022), Bala-Cynwyd · على بُعد 5 ميل
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
جارٍ التسجيلالمرحلة 3
- MidLantic urology, Bala-Cynwyd · على بُعد 5 ميل
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
جارٍ التسجيلالمرحلة 2/3
- Fox Chase Cancer Center, Philadelphia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Philadelphia MultiService Center, Philadelphia, PA, Philadelphia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
جارٍ التسجيلالمرحلة 3
- Perelman Center for Advanced Medicine ( Site 0067), Philadelphia
- Abramson Cancer Center - Penn Medicine ( Site 0079), Philadelphia
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
جارٍ التسجيلالمرحلة 1/2
- GSK Investigational Site, Philadelphia
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Philadelphia
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
جارٍ التسجيل
- MidLantic Urology, Bala-Cynwyd · على بُعد 5 ميل
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
جارٍ التسجيلالمرحلة 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · على بُعد 23 ميل
- Christiana Care Health System-Wilmington Hospital, Wilmington · على بُعد 25 ميل
A Study of Tarlatamab for People With Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Thomas Jefferson University Hospital, Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Philadelphia
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
جارٍ التسجيلالمرحلة 2
- Abramson Cancer Center of the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
جارٍ التسجيلالمرحلة 3
- Penn Presbyterian Medical Center, Philadelphia
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University Honickman Center, Philadelphia
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Philadelphia
PSMA PET Combined With MRI for the Detection of PCa
جارٍ التسجيلالمرحلة 3مرحباً بالمتطوعين الأصحاء
- MidLantic Urology, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1
- Investigative Site #109, Philadelphia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
جارٍ التسجيلالمرحلة 3
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · على بُعد 23 ميل
- Christiana Care Health System-Wilmington Hospital, Wilmington · على بُعد 25 ميل
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1
- MidLantic Urology, Bala-Cynwyd · على بُعد 5 ميل
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Philadelphia
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Thomas Jefferson University Hospital, Philadelphia
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
جارٍ التسجيلالمرحلة 2
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia
TERPS Trial for de Novo Oligometastic Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
جارٍ التسجيلدراسة رصدية
- Fox Chase Cancer Center - Temple Health, Philadelphia
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
جارٍ التسجيل
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
جارٍ التسجيلالمرحلة 2/3
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
جارٍ التسجيلالمرحلة 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Study of AZD0754 in Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Research Site, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
جارٍ التسجيلالمرحلة 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
Hypofractionated WPPT With HDR Boost
جارٍ التسجيلالمرحلة 2
- University of Pennsylvania, Philadelphia
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
جارٍ التسجيلالمرحلة 1
- MidLantic Urology, Bala-Cynwyd · على بُعد 5 ميل
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
جارٍ التسجيلالمرحلة 4
- Albert Einstein Healthcare Network, Philadelphia
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
جارٍ التسجيلالمرحلة 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · على بُعد 23 ميل
- Christiana Care Health System-Wilmington Hospital, Wilmington · على بُعد 25 ميل
Prostate Tissue BioBank
جارٍ التسجيلدراسة رصدية
- University of Pennsylvania, Philadelphia
Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
جارٍ التسجيل
- Fox Chase Cancer Center, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, Philadelphia
تجارب سرطان البروستاتا في مدن أخرى
- New York City, NY103 دراسات
- Houston, TX76 دراسات
- Los Angeles, CA61 دراسات
- Boston, MA59 دراسات
- St. Louis, MO46 دراسات
- Chicago, IL45 دراسات
- San Francisco, CA45 دراسات
- Baltimore, MD43 دراسات
- Nashville, TN43 دراسات
- Seattle, WA42 دراسات
- Washington, DC38 دراسات
- Dallas, TX36 دراسات
دراسات أخرى في Philadelphia
- السرطان (جميع الأنواع)59 دراسات
- سرطان الثدي56 دراسات
- سرطان الرئة غير صغير الخلايا51 دراسات
- السرطان النقيلي46 دراسات
- سرطان القولون والمستقيم44 دراسات
- سرطان المبيض44 دراسات
- سرطان الرئة36 دراسات
- ابيضاض الدم النقوي الحاد34 دراسات
- قصور القلب31 دراسات
- سرطان بطانة الرحم28 دراسات
- الاكتئاب26 دراسات
- سرطان البنكرياس26 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.